France – Research and development services and related consultancy services – Projet aRTwin Plateforme de jumeaux numériques hybrides (biophysique et IA multimodale) pour la radiothérapie et l'hadronthérapie
This procurement notice was published by CENTRE FRANCOIS BACLESSE in France on 2026-11-11. The contract covers R&Dservices under CPV classification 73000000, 73111000, and follows a neg-w-call procedure in accordance with EU Directive 2014/24/EU. The estimated contract value is 1425000. The submission deadline is 12/08/2026. This notice is open to all qualified suppliers across EU member states and is sourced directly from TED Europa — the official EU procurement journal.
| Notice ID | 786215-2026 |
| Contracting Authority | CENTRE FRANCOIS BACLESSE |
| Country | France (FRA) |
| Sector | R&D |
| Estimated Value | 1425000 |
| Submission Deadline | 12/08/2026 |
| Published | 2026-11-11 |
| Procedure Type | neg-w-call |
| Notice Type | cn-standard |
| CPV Codes | 73000000, 73111000, 72000000 |
| Contract Period | Dec 21, 2026 – Nov 30, 2028 |
| Submission Languages | French |
| Authority Type | Body Governed by Public Law |
Contract Description
Le projet aRTwin, cofinancé par l'Union européenne (FEDER, programme Région Normandie), vise à construire une plateforme de jumeaux numériques hybrides, associant modèles biophysiques et radiobiologiques et intelligence artificielle multimodale, pour la radiothérapie et l'hadronthérapie (protons et ions carbone ; ions hélium à titre facultatif). Les travaux portent sur la recherche et l'évaluation ; aucune utilisation clinique n'est prévue dans le cadre du marché. Le marché est décomposé en trois lots : lot 1 - données et modélisation (base de données multimodale, modélisation biophysique et radiobiologique, IA, jumeaux numériques simulés couplés au logiciel de planification RayStation), en régie, en format hybride selon un planning trimestriel de présence sur site ; lot 2 - recherche préclinique en hadronthérapie (production ou réanalyse de données expérimentales, existantes ou produites pendant le marché, sur l'hypoxie et la radiorésistance ; tranche ferme in vitro et tranche optionnelle in vivo) ; lot 3 - plateforme, infrastructure et architecture (architecture, plateforme intégrative, interopérabilité DICOM / FHIR, chaîne MLOps), en régie, en format hybride selon un planning trimestriel de présence sur site, sans fourniture de matériel. Le traitement des données de santé est réalisé exclusivement dans les locaux du Centre. Les prestations s'achèvent au plus tard le 30 novembre 2028, date prolongeable de douze mois au plus. Le Centre se réserve la possibilité de confier aux titulaires des marchés de prestations similaires (article R. 2122-7 du Code de la commande publique).
How to Apply
This R&D contract is open under a neg-w-call procedure in accordance with EU Directive 2014/24/EU. Suppliers must comply with the eligibility conditions specified in the procurement documents.
- Access the official notice on TED Europa →
- Download the procurement documents from the contracting authority's e-procurement portal
- Prepare your European Single Procurement Document (ESPD) and technical offer
- Submit your bid before 12/08/2026
Contracting Authority
Classification (CPV Codes)
CPV (Common Procurement Vocabulary) codes classify the subject of the contract.
Frequently Asked Questions
Can I still bid on tender 786215-2026?
Yes. The submission deadline for notice 786215-2026 is 12/08/2026. This is a neg-w-call procedure published under EU Directive 2014/24/EU. All qualified suppliers across EU member states may submit a bid via the official TED Europa notice.
Who is the contracting authority for 786215-2026?
The contracting authority is CENTRE FRANCOIS BACLESSE based in France. Contact email: e.paillard@baclesse.unicancer.fr.
What is the estimated contract value for this R&D tender?
The estimated contract value is 1425000 (excl. VAT). This is an indicative figure published by the contracting authority in accordance with EU procurement rules.
What procedure type is used for tender 786215-2026?
This tender uses a neg-w-call procedure. Review the official TED notice for full eligibility conditions.
What sector and CPV codes apply to this notice?
This procurement covers the R&D sector under CPV codes 73000000, 73111000. It was published by CENTRE FRANCOIS BACLESSE in France and sourced from TED Europa — the Official Journal of the EU.
Related EU Procurement Guides